Sign in
Not yet taking people in PortugalNo phase

Comparing Two Ways to Set Exercise Levels in Chronic Obstructive Pulmonary Disease

Compares two methods of planning exercise in adults with chronic obstructive pulmonary disease.

Key facts

Who runs it
Aveiro University
Where
Aveiro, PortugalSee the site
Trial code
Registry title
FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
Status
Not yet recruiting
People taking part
46 people, planned
Started
1 Sept 2026
Expected to end
31 Jul 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Pulmonary rehabilitation programme
Record updated
1 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a clinical diagnosis of COPD who can complete a maximal exercise test and join a pulmonary rehabilitation programme.

Age
18 years or older
Sex
All sexes can join
Disease stage
Clinical diagnosis of COPD
Earlier treatment
Cannot have taken part in pulmonary rehabilitation in the last 12 months
Biomarker or test result
Must complete a maximal exercise test (CPET) in which the first metabolic threshold (MT1) is identified

Main reasons for not taking part

  • Unstable or significant conditions (for example muscle, bone, nerve, heart, cancer or immune conditions) that make the rehabilitation programme not possible
  • Took part in pulmonary rehabilitation in the last 12 months

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Clinical diagnosis of COPD
  • Complete a maximal CPET with MT1 identification

Who cannot take part

  • Presence of unstable or significant conditions (e.g. musculoskeletal, neurological, cardiovascular, neoplasia or immunological) that renders the participation in the pulmonary rehabilitation program infeasible
  • Participated in pulmonary rehabilitation in the last 12 months

Where in Portugal

  • University of AveiroAveiro, PortugalContact: Alda S Marques, PhDNot yet recruiting

About the trial

What the trial wants to find out

This randomised controlled trial aims to: i) compare the power output at the first metabolic threshold (WMT1) between the MT1 and the six-minute walking test (6MWT)-based cardiorespiratory exercise prescriptions in chronic obstructive pulmonary disease (COPD); ii) compare exercise adherence, peripheral muscle strength, health-related quality of life, dyspnoea, fatigue, disease impact and emotional status between MT1 and 6MWT-based exercise prescriptions.

Read full original descriptionShow less

Patients will be recruited via the pulmonology services from Unidade Local de Saúde do Baixo Mondego and Unidade Local de Saúde de Aveiro.

The 2 groups in the trial

  • Metabolic Threshold-based exercise intensity prescriptionTreatment being tested

    Treatment: Pulmonary rehabilitation programme

  • Six-minute walking test-based exercise intensity prescriptionExisting treatment, for comparison

    Treatment: Pulmonary rehabilitation programme

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
Plain-language title
Comparing Two Ways to Set Exercise Levels in Chronic Obstructive Pulmonary DiseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
1 September 2026